TAKEDA PHARMACEUTICAL COMPANY LIMITED Quotes Takeda Pharmaceutical Company Limited Börse Stuttgart
Equities
TKD
JP3463000004
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.41 EUR | +2.95% |
|
-3.34% | -8.17% |
| 24/06 | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
| 24/06 | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Quotes 5-day view
Delayed Quote Börse Stuttgart| 19/06/2024 | 20/06/2024 | 21/06/2024 | 24/06/2024 | 25/06/2024 | |
|---|---|---|---|---|---|
| Last | 23.73 € | 23.45 € | 23.42 € | 23.71 € | 23.71 € |
| Volume | 100 | 0 | 750 | 0 | 0 |
| Change | -0.54% | -1.18% | -0.13% | +1.24% | +2.95% |
| Opening | 23.73 | 23.45 | 23.46 | 23.71 | 23.71 |
| High | 23.73 | 23.45 | 23.46 | 23.71 | 23.71 |
| Low | 23.73 | 23.45 | 23.42 | 23.71 | 23.71 |
Performance
| 1 week | -3.34% | ||
| Current month | -2.63% | ||
| 1 month | -3.07% | ||
| 3 months | -11.13% | ||
| 6 months | -6.95% | ||
| Current year | -8.17% | ||
| 1 year | -19.11% | ||
| 3 years | -15.20% | ||
| 5 years | -21.93% | ||
| 10 years | -30.04% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
6 414 475 800 702
Capitalization (USD)
40 231 592 222
Net sales (JPY)
4 263 762 000 000
Net sales (USD)
26 742 315 264
Free-Float
99.12 %
Free-Float capitalization (EUR)
6 412 706 941 579
Free-Float capitalization (USD)
40 220 497 938
Average Daily Capital Traded
0%
Highs and lows
1 week
23.42
23.86
1 month
23.4224.92
3 years
23.2431.72
5 years
23.2437.82
10 years
23.2450.30
Indicators
Moving average 5 days
23.63
Moving average 20 days
24.26
Moving average 50 days
24.39
Moving average 100 days
25.33
Price spread / (MMA5)
-3.18%
Price spread / (MMA20)
-0.62%
Price spread / (MMA50)
-0.09%
Price spread / (MMA100)
+3.78%
STIM
RSI 9 days
28.79
RSI 14 days
35.57
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -5.46% | ||
| 2023 | -11.18% | ||
| 2022 | +21.68% | ||
| 2021 | -20.23% | ||
| 2020 | -15.14% | ||
| 2019 | +21.58% | ||
| 2018 | -38.25% | ||
| 2017 | +20.87% | ||
| 2016 | -15.60% | ||
| 2015 | +36.12% | ||
| 2014 | -0.39% | ||
| 2013 | +2.04% | ||
| 2012 | -0.03% | ||
| 2011 | -9.10% | ||
| 2010 | +30.17% | ||
| 2009 | -21.58% | ||
| 2008 | -8.56% | ||
| 2007 | -24.34% | ||
| 2006 | +14.02% | ||
| 2005 | +25.75% | ||
| 2004 | +14.56% | ||
| 2003 | -19.02% | ||
| 2002 | -22.73% | ||
| 2001 | -17.21% | ||
| 2000 | +25.77% | ||
| 1999 | +56.79% | ||
| 1998 | +19.80% | ||
| 1997 | +62.90% |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock
- Quotes Takeda Pharmaceutical Company Limited
